study 302 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

261,947 results for “study 302”

Trials

View all 235948 →

Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

500 participants · First posted Jun 24, 2020

Study of COYA 302 for the Treatment of ALS

120 participants · First posted Sep 9, 2025

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

150 participants · First posted Mar 6, 2026

Drugs

View all 2812 →

JN-302

Allogeneic lymphocytes(German CLL Study Group)

AJ-302

Organizations

View all 59 →

HUNTINGTON STUDY GROUP

United States

German CLL Study Group

Germany

Korean Cancer Study Group

South Korea

News

View all 23128 →

FDA Approves Denileukin Diftitox (Lymphir) for Relapsed/Refractory Cutaneous T-Cell Lymphoma

Denileukin Diftitox Added to NCCN Guidelines for Cutaneous T-Cell Lymphoma

Relmada Therapeutics Announces Positive Progress in MDD and Metabolic Disease Programs

Page 1 of 26195